Trial
NCT06580938
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Non Small Cell Lung Cancer
Intervention
PF-07921585
Why stopped
The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-23